Aptamer Group signs product development partnership with Microsaic Systems

LONDON: Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announced a partnership with Microsaic Systems plc to develop a panel of Optimer binders for integration into a water testing system. Microsaic has recently purchased the Microtox® water testing system. Earlier work with Aptamer’s COVID-19…

Wellfully joins forces with Dolce Cann Global on medicinal cannabis product development

SYDNEY: Wellfully Limited will engage in collaboration with NSW-based Dolce Cann Global Ltd Pty to develop cannabinoid products using its patented drug delivery system. To this end, the Company has entered into a binding Collaboration Agreement with Dolce, by which parties have agreed to an initial trial period for joint research and development, following which…

Medherant partners with Cycle Pharmaceuticals to develop new products

LONDON: Medherant Ltd, the transdermal drug delivery company, has entered into a partnership with Cycle Pharmaceuticals to develop new products using Medherant’s proprietary TEPI Patch technology. Mercia Asset Management PLC holds a 30.1% direct stake in Medherant Ltd. Under the terms of the partnership, Medherant will receive an initial upfront licence payment with an additional…